(Q40151296)
Statements
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer (English)
Kalyani Narra
Stefanie R Mullins
Hyung-Ok Lee
Brenda Strzemkowski-Brun
Kimberly Magalong
Victoria J Christiansen
Patrick A McKee
Steven J Cohen
Louis M Weiner
Neal J Meropol
Jonathan D Cheng